Rhumbline Advisers Invests $116,000 in ASP Isotopes Inc. (NASDAQ:ASPI)

Rhumbline Advisers bought a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) during the second quarter, according to its most recent filing with the SEC. The firm bought 38,056 shares of the company’s stock, valued at approximately $116,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares during the period. HTLF Bank increased its stake in shares of ASP Isotopes by 197.0% in the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock worth $323,000 after purchasing an additional 70,000 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of ASP Isotopes during the 2nd quarter worth about $381,000. Virtu Financial LLC boosted its stake in ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after purchasing an additional 69,176 shares during the period. Finally, Rathbones Group PLC acquired a new stake in ASP Isotopes in the 4th quarter valued at approximately $272,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, major shareholder Ak Jensen Investment Managemen acquired 70,000 shares of the stock in a transaction dated Monday, July 8th. The shares were bought at an average cost of $3.05 per share, for a total transaction of $213,500.00. Following the purchase, the insider now owns 6,586,874 shares in the company, valued at approximately $20,089,965.70. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 26.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright cut their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th.

ASP Isotopes Price Performance

Shares of ASP Isotopes stock opened at $2.78 on Tuesday. The company has a debt-to-equity ratio of 2.06, a current ratio of 4.00 and a quick ratio of 4.00. The company has a market cap of $143.90 million, a PE ratio of -5.25 and a beta of 5.11. The firm has a fifty day moving average price of $2.48 and a two-hundred day moving average price of $3.36. ASP Isotopes Inc. has a fifty-two week low of $0.84 and a fifty-two week high of $5.67.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million during the quarter. Analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current year.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.